title: Deferred treatment for clinically localized prostate cancer.
abstract: With the available data, deferred treatment is definitely an option for patients with low grade clinically localized prostate cancer if their life expectancy is 10 years or less and avoids the side-effects of treatment. Many patients will avoid the need for therapy of their prostate cancer during their remaining lifetime.
authors.affiliation: Department of Urology, Karolinska Hospital, Stockholm, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Adolfsson
mesh_terms: D000367:Age Factors; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006801:Humans; D008017:Life Expectancy; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D016019:Survival Analysis; D013997:Time Factors